Precision Antibody will attend Antibody Engineering & Therapeutics Europe, June 10–12, 2025, in Basel, to showcase its high-specificity monoclonal antibody solutions for accelerating therapeutic discovery.

Precision Antibody CEO Dr. Ginette Serrero to speak at the 23rd BioPharma Drug Discovery Nexus, May 7–8 in San Francisco, on advancing monoclonal antibody development for early-stage drug discovery.

Precision Antibody will showcase its cutting-edge custom antibody solutions at INTERPHEX Week Osaka 2025, focusing on regenerative medicine, therapeutics, and industry collaborations.